Vibro-acoustic therapy

 Vibrotactile / vibroacoustic therapy (VAT) uses low-frequency sound (typically ~20–100 Hz) delivered to your body to stimulate mechanoreceptors, encourage autonomic balance, relax muscle tone, and modulate pain perception. It’s a somatic intervention rooted in neuroscience. Not hype. 

Clinically proven low-frequency vibration can do what many treatments can’t — reduce pain naturally. Vibrotactile therapy technology builds on decades of vibroacoustic research showing measurable pain relief across multiple conditions.

• Fibromyalgia Clinical Study: Low-frequency sound stimulation led to significant reductions in pain intensity and improved daily function.
• BMJ Open Scoping Review (2022): Across adult pain studies, vibroacoustic therapy showed consistent analgesic benefits and high tolerability, prompting calls for large-scale randomized trials.
• Metodo Frequency® Case Report (Dr. Giovanni Peduto): Using Woojer devices, this clinical case documented rapid pain relief for dysmenorrhea, ovulation pain, and PCOS-related inflammation.
• Post-Herpetic Neuralgia Case Report (2021): Low-frequency sound therapy reduced chronic nerve pain, improved mood, and enhanced sleep quality.
• Ehlers–Danlos Syndrome Pilot Study (2020): Vibroacoustic stimulation decreased pain interference and improved sleep among chronic-pain participants.

Together, these studies suggest that targeted low-frequency vibration can help modulate pain pathways, improve comfort, and restore balance, without drugs or side effects.

Early evidence suggests vibroacoustic therapy may support attention and emotion regulation in autistic children, using low-frequency vibrations similar to Woojer's technology. Mixed-methods pilot (Healthcare, 2025)

This study investigates whether tactile stimuli modulation disorders are linked to insomnia in individuals with ASD. Low-frequency tactile interventions, like those used in Woojer, could help improve sleep quality in this population. MDPI

A pilot study exploring a wearable vibrotactile device, delivering low-frequency vibrations to help with sensory processing and sleep in individuals with ASD, showing similarities to Woojer’s technology. PMC

Reviews indicate that vibroacoustic therapy, including rhythmic low-frequency approaches, can help improve motor control and gait in Parkinson's disease. This is similar to the therapeutic use of Woojer technology for motor function. Frontiers in Aging Neuroscience (2020)

This research highlights how coordinated reset vibrotactile stimulation, a form of low-frequency stimulation, can lead to long-term improvements in motor symptoms of Parkinson’s, akin to the therapeutic effects Woojer devices aim for. PMC

This study explores binaural acoustic stimulation, a form of low-frequency vibrotactile stimulation, for improving motor performance in Parkinson’s disease. The effects are similar to those achieved by Woojer's low-frequency technology in therapeutic contexts. Frontiers

This study examines the effects of low-frequency vibrotactile stimulation on sleep power topography in children with ADHD, showing that low-frequency sound can aid in improving sleep and focus, similar to Woojer’s technology for stress and sleep. PMC

A clinical trial investigating the impact of high and low-frequency paired associative deep transcranial magnetic stimulation on ADHD symptoms. This low-frequency intervention is comparable to Woojer's technology, which uses similar principles for therapeutic benefits. ClinicalTrials.gov